UNCY News

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics, Inc. Securities Lawsuit - Contact Portnoy Law Firm

Deadline Alert: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

UNCY Deadline Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of Securities Class Action Deadline on November 2, 2026

Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY)

Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class Action - Contact Levi & Korsinsky

Bronstein, Gewirtz & Grossman LLC Urges Unicycive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Contact Levi & Korsinsky by November 2, 2026 to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline November 2, 2026

Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Investors – Lead Plaintiff Deadline on November 2, 2026